Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.7K
1.7K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.4K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

2.9K
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Risk Factors and Colorectal Cancer Incidence: A Predictive Analytics Framework.

Studies in health technology and informatics·2026
Same author

A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies.

JCO clinical cancer informatics·2026
Same author

Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols.

PloS one·2026
Same author

Cognitive behavioural therapy compared to control conditions in treating bulimia nervosa and binge-eating disorder: A systematic review and meta-analysis.

The British journal of clinical psychology·2026
Same author

Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.

JCO precision oncology·2026
Same author

Network analysis of quality of life and depression in a randomized breast cancer trial with ten-years follow-up.

Scientific reports·2026

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K

Workflow-driven clinical decision support for personalized oncology.

Anca Bucur1, Jasper van Leeuwen2, Nikolaos Christodoulou3

  • 1Precision and Decentralized Diagnostics, Philips Research, Eindhoven, The Netherlands. anca.bucur@philips.com.

BMC Medical Informatics and Decision Making
|July 28, 2016
PubMed
Summary
This summary is machine-generated.

Clinical Decision Support (CDS) frameworks in oncology face adoption barriers due to complexity and rapid knowledge changes. Our new p-medicine framework integrates clinical models and workflows for better decision-making and adoption.

Keywords:
CDS adoptionClinical decision supportClinical workflowsKnowledge modelsOncology

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.8K

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.8K

Area of Science:

  • Oncology
  • Medical Informatics
  • Clinical Decision Support Systems

Background:

  • Clinical Decision Support (CDS) in oncology aims to manage complexity and bridge the research-practice gap, but faces limited clinical uptake.
  • Existing oncology CDS solutions struggle with complex patient stratification, personalized treatment decisions, and rapidly evolving therapeutic knowledge.

Purpose of the Study:

  • To propose a novel framework for efficient implementation of meaningful CDS in oncology.
  • To address the limitations of current CDS by incorporating diverse clinical knowledge models and leveraging real-world data.

Main Methods:

  • Developed a framework integrating literature-based and p-medicine project-derived clinical knowledge models.
  • Designed an architecture extending the CDS framework with workflow functionality to embed clinical models within clinical processes.
  • Ensured the framework supports collaboration and reuse of models within the biomedical community.

Main Results:

  • The p-medicine CDS framework enables comprehensive solutions by leveraging the latest domain knowledge.
  • Integrated clinical models and workflow execution ensure recommendations are delivered at the point of need.
  • The framework supports complex decision-making and adapts to the dynamic nature of oncology.

Conclusions:

  • The presented CDS framework and its implementation in p-medicine effectively support complex clinical decisions.
  • By embedding clinical knowledge in workflows, the solution enhances decision processes and knowledge exploitation.
  • This approach aims to increase CDS adoption and improve patient management in oncology.